For careful comparison
Questions about reported ibogaine aftereffects belong beside clear statements of what a source can actually show.
Near Beacon 44 · About the resource
Near Beacon 44 is an independent resource built for careful reading. Sparring Glass exists to separate emerging evidence, documented risk, ethics, and regulation from certainty that the available record does not support.
01 / Why this exists
This resource was made for athletes, veterans, families, coaches, and advocates who need a clearer way to assess difficult claims and incomplete evidence. It covers ibogaine and brain injury in athletic and tactical populations without presenting preliminary findings as settled care.
Our work begins with the same question that guides the broader brain-injury case review: what is documented, what remains uncertain, and what limits should a reader understand before drawing a conclusion?
02 / Editorial approach
“A useful resource should show its limits as clearly as its findings.”Near Beacon 44 organizes information so the strength, source, and limits of a claim remain visible.
We look for research literature, study registries, official sources, regulatory materials, and primary documentation where available. We distinguish what a source says from what can reasonably be inferred from it.
Study records can be checked against the public database maintained by ClinicalTrials.gov, while terminology and evidence limits are explained without treating registration as proof of benefit or safety.
03 / What we cover
Information is arranged around evidence, safety, guidance, and the language readers encounter in public claims. The aim is to help people locate context without collapsing different types of information into one verdict.
Our resource pathways explain how this material is organized, while pages discussing ibogaine’s other names help readers recognize terms that can otherwise obscure what a source is referring to.
04 / Source discipline
We use source type as part of the interpretation. A study, a registry entry, an official notice, a personal account, and a commercial statement each answer different questions and carry different limits.
Where a source describes reported outcomes, readers may encounter discussions of ibogaine success rates; those summaries need to be read alongside design, selection, follow-up, and the difference between a reported result and an established finding.
Public safety communications matter too. The FDA’s controlled-substances information is one official starting point for understanding why source context and regulatory language should not be reduced to marketing shorthand.
Method note: Near Beacon 44 does not treat anecdote as proof, commercial availability as endorsement, or lack of a public record as evidence that no risk exists.
05 / Independent by design
This is an independent information resource. It does not provide medical or legal advice, diagnose conditions, recommend treatment, or direct people to providers.
Questions about reported ibogaine aftereffects belong beside clear statements of what a source can actually show.
Material concerning ibogaine and depression claims is approached with the same distinction between preliminary discussion and established care.
Any discussion of treatment centers in the United States should be read as general context, not as a provider recommendation or referral.
References to ibogaine plant seeds are included only to clarify public language, not to encourage acquisition, use, or self-treatment.
For a broader standard on evaluating health information, the National Library of Medicine’s guidance on evaluating health information offers a practical reminder to check source, purpose, currency, and evidence.
View the evidence review